organophosphonates has been researched along with Thrombopenia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Korman, T; Lee, LY; Quach, H; Smith, B; Woolley, IJ | 1 |
Amato, A; Gaeta, GB; Stornaiuolo, G | 1 |
Asbury, R; Ball, H; Blessing, JA; Podczaski, E | 1 |
Bonnet, JD; Braun, TJ; Crowley, J; Hanson, KH; Keppen, M; Salmon, SE | 1 |
2 trial(s) available for organophosphonates and Thrombopenia
Article | Year |
---|---|
A phase II trial of amonafide in patients with mixed mesodermal tumors of the uterus: a Gynecologic Oncology Group study.
Topics: Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Imides; Isoquinolines; Leukopenia; Middle Aged; Mixed Tumor, Mesodermal; Naphthalimides; Organophosphonates; Thrombocytopenia; Uterine Neoplasms | 1998 |
Evaluation of amonafide in refractory and relapsing multiple myeloma: a Southwest Oncology Group study.
Topics: Adenine; Adult; Aged; Antineoplastic Agents; Blood Cell Count; Drug Resistance; Female; Granulocytes; Humans; Imides; Isoquinolines; Leukopenia; Male; Middle Aged; Multiple Myeloma; Naphthalimides; Organophosphonates; Recurrence; Thrombocytopenia | 1991 |
2 other study(ies) available for organophosphonates and Thrombopenia
Article | Year |
---|---|
Successful use of eltrombopag without splenectomy in refractory HIV-related immune reconstitution thrombocytopenia.
Topics: Adenine; Benzoates; Deoxycytidine; Drug Combinations; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV Seropositivity; Humans; Hydrazines; Immune Reconstitution Inflammatory Syndrome; Male; Middle Aged; Organophosphonates; Oxazines; Pyrazoles; Reverse Transcriptase Inhibitors; Thrombocytopenia; Treatment Outcome | 2012 |
Adefovir dipivoxil-associated thrombocytopenia in a patient with chronic hepatitis B.
Topics: Adenine; Antiviral Agents; Hepatitis B, Chronic; Humans; Male; Middle Aged; Organophosphonates; Thrombocytopenia | 2006 |